pharmaphorum Editor-in-Chief Jonah Comstock welcomes Amy Abernethy, president of Verily's Clinical Studies Platforms and Jennifer Goldsack, CEO of the Digital Medicine Soci
As Frontiers Health approaches, we’re featuring interviews with members of the steering committee to give you a sneak peek of what to expect in Milan. Interested in signing up?
Adam Hutchinson, founder of oVRcome, discusses the weight the New Zealand-based company places on ensuring the accuracy and effectiveness of its virtual reality (VR) treatments through clin
AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient gr